Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells

1. Emerging strategies to reduce the side effects of CAR-T cell therapy: focusing on gene editing and nanotechnology

   Jinxin Dong, Denis Nikolenko, Shuxrat Boymuradov +2

   МақолаCAR-T cell therapy researchClinical & Translational Oncology20261 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.000172

2. Epigenetic insights and innovations for overcoming barriers in CAR-T cell therapy for cancer

   Viktoria B. Poluektova, Svetlana N. Zuevskaya, Yarmatov Suvon +3

   МақолаCAR-T cell therapy researchClinical & Translational Oncology20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.008555